Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Lymphoma 26Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Leukemia 17Lymphoma, Non-Hodgkin 16Sarcoma 9Leukemia, Myeloid, Acute 9Hodgkin Disease 9Hematologic Neoplasms 9Neuroblastoma 8Neoplasms 8Myelodysplastic Syndromes 7Leukemia, Lymphocytic, Chronic, B-Cell 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Burkitt Lymphoma 6Osteosarcoma 5Melanoma 5Lymphoma, Mantle-Cell 5Lymphoma, Follicular 5Breast Neoplasms 5Rhabdoid Tumor 4Retinoblastoma 4Multiple Myeloma 4Medulloblastoma 4Lymphoma, Large B-Cell, Diffuse 4Wilms Tumor 3Recurrence 3Neoplasms, Germ Cell and Embryonal 3Myeloproliferative Disorders 3Hepatoblastoma 3Graft vs Host Disease 3

Interventions

Dexamethasone 29Aprepitant 24Palonosetron 20Ondansetron 20Calcium Dobesilate 13Olanzapine 12Granisetron 11Therapeutics 7fosaprepitant 6Doxorubicin 6Cyclophosphamide 6dexamethasone acetate 5netupitant 4Vincristine 4dolasetron 3Yoga 3Tropisetron 3Surveys and Questionnaires 3Psychiatric Rehabilitation 3Prochlorperazine 3Metoclopramide 3Lorazepam 3Dronabinol 3Acupressure 3peppermint oil 2netupitant, palosentron drug combination 2ginger extract 2dexamethasone 21-phosphate 2Sugars 2Rituximab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Nausea × Mesna × Clear all
NCT01490060 2016-04-11

Fosaprepitant in Patients Receiving Ifosfamide-based Regimen

M.D. Anderson Cancer Center

Phase NA Completed
47 enrolled 6 charts
Sarcoma

Nausea, Neoplasms, Sarcoma, Vomiting

NCT00410488 2013-03-22

Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)

M.D. Anderson Cancer Center

Phase NA Completed
51 enrolled 5 charts
Sarcoma

Nausea, Sarcoma, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡